Implementation and impact of the RTS,S/AS01 malaria vaccine on infants and implications for pregnancy in Rwanda: Operational and programmatic insights
Aymar Akilimali(Roslin Institute), Christian Tague(University of Goma), Innocent Mufungizi(Green Circle), Zubayer Shams(Brunel University of London), Amidu Alhassan(University of Cape Coast), Mc Juan Muco Mugisha, Samson Hangi, S. Rizvi(Jinnah Sindh Medical University), Jones Onesime(Université libre des Pays des Grands Lacs), Adolphe Karegeya(University of Utah), Dujardin Makeda(Unknown), Freddy Zihindula(Université Evangélique en Afrique), Fabien Imani Shangalume(Evangel University), Calvin R. Wei, Syeda Vilay Zehra Rizvi(Jinnah Sindh Medical University), Diya Rathi(Dow University of Health Sciences), Ruchi Jwalit Shah(M. P. Shah Medical College), Sabika Fatima(Jinnah Sindh Medical University), Godfred Yawson Scott(Kwame Nkrumah University of Science and Technology)
Cited by 0
Related Papers
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
|Annals of Medicine and Surgery|2024|87
Impacts of the advancement in artificial intelligence on laboratory medicine in low‐ and middle‐income countries: Challenges and recommendations—A literature review
|Health Science Reports|2024|62
Revolutionary breakthrough: FDA approves Vyjuvek, the first topical gene therapy for dystrophic epidermolysis bullosa
|Annals of Medicine and Surgery|2023|30
Self-medication and Anti-malarial Drug Resistance in the Democratic Republic of the Congo (DRC): A silent threat
|Tropical Medicine and Health|2022|29